Back
Revance Therapeutics Stock Price Chart
Elon Musk Predicts MAJOR Crisis in Trump's First Year
See Why Investors are Pouring Mountains of Cash into Certain Companies Trump Wants to Solve the Problem.
Sell
17
RVNC
Revance Therapeutics
Last Price:
$3.08
Seasonality Move:
-2.77%
7 Day Trial
ALL ACCESS PASS
$
7
FREE REPORT: 2025 Gold Price Outlook
Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.-
The current trend is relatively stagnant and RVNC is experiencing buying pressure, which is a positive indicator for future bullish movement.
Revance Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.08 | Buy |
| 20-day SMA: | 3.39 | Sell |
| 50-day SMA: | 4.28 | Sell |
| 200-day SMA: | 4.34 | Sell |
| 8-day EMA: | 3.11 | Sell |
| 20-day EMA: | 3.39 | Sell |
| 50-day EMA: | 4.02 | Sell |
| 200-day EMA: | 5.51 | Sell |
Revance Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.35 | Sell |
| Relative Strength Index (14 RSI): | 33.5 | Sell |
| Chaikin Money Flow: | 407565 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.07 - 3.87) | Sell |
| Bollinger Bands (100): | (3.72 - 6.28) | Sell |
Revance Therapeutics Technical Analysis
| Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 23 | Dec 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | 23 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Revance Therapeutics Stock
Is Revance Therapeutics Stock a Buy?
-
Revance Therapeutics share price is 3.08 while RVNC 8-day simple moving average is 3.08, which is a Buy signal.
-
The stock price of RVNC is 3.08 while Revance Therapeutics 20-day SMA is 3.39, which makes it a Sell.
-
Revance Therapeutics 50-day simple moving average is 4.28 while RVNC share price is 3.08, making it a Sell technically.
-
RVNC stock price is 3.08 and Revance Therapeutics 200-day simple moving average is 4.34, creating a Sell signal.
RVNC Technical Analysis vs Fundamental Analysis
Sell
17
Revance Therapeutics (RVNC)
is a Sell
Is Revance Therapeutics a Buy or a Sell?
-
Revance Therapeutics stock is rated a SellThe current Revance Therapeutics [RVNC] share price is $3.08. The Score for RVNC is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Revance Therapeutics Stock Info
Market Cap:
323.1M
Price in USD:
3.08
Share Volume:
407.6K
Revance Therapeutics 52-Week Range
52-Week High:
9.75
52-Week Low:
2.30
Sell
17
Revance Therapeutics (RVNC)
is a Sell
Revance Therapeutics Share Price Forecast
-
What is the Revance Therapeutics stock price today?The Revance Therapeutics stock price is 3.08 USD today.
-
Will RVNC stock go up or go down?Revance Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Revance Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Revance Therapeutics is overvalued.
Is Revance Therapeutics Stock a Buy?
-
Revance Therapeutics share price is 3.08 while RVNC 8-day exponential moving average is 3.11, which is a Sell signal.
-
The stock price of RVNC is 3.08 while Revance Therapeutics 20-day EMA is 3.39, which makes it a Sell.
-
Revance Therapeutics 50-day exponential moving average is 4.02 while RVNC share price is 3.08, making it a Sell technically.
-
RVNC stock price is 3.08 and Revance Therapeutics 200-day simple moving average is 5.51, creating a Sell signal.
Fundamental Analysis of Revance Therapeutics
Is Revance Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.31 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.38 per share, and an increase next year of $0.63 per share.
Technical Analysis of Revance Therapeutics
Should I short Revance Therapeutics stock?
-
RVNC Moving Average Covergence Divergence (MACD) indicator is -0.35, suggesting Revance Therapeutics is a Sell
-
Revance Therapeutics Relative Strength Index (RSI) is 33.5, which suggest Revance Therapeutics is oversold
-
The Bollinger Bands (25) for Revance Therapeutics is (3.07 - 3.87), which suggest Revance Therapeutics is a Sell
-
The Bollinger Bands (100) for Revance Therapeutics is (3.72 - 6.28), which suggest Revance Therapeutics is a Sell
* Revance Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.